Anticancer agent 264

Anticanceragent 264 (Compound 5w) is a small molecule research compound with antiproliferative activity (IC50 7.5-33.67 μM) that induces G2/M phase arrest in various cancer cell lines. It functions by downregulating CDK1, CDK2, and Cyclin B1 and is used for in vitro studies in cancer research, including investigations into cell cycle mechanisms.